Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program Experience

Journal of Clinical Oncology

Volumn 23, Issue 27, 2005, Pages 6682-6689

  Buchanan, David R ^a   White, Jeffrey D ^a   O'Mara, Ann M ^a   Kelaghan, Joseph W ^a   Smith, Wendy B ^a   Minasian, Lori M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CHAMOMILE; CIMICIFUGA RACEMOSA EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; KAVA EXTRACT; PLANT EXTRACT; VALERIAN;

ALTERNATIVE MEDICINE; ARTICLE; CANCER; CANCER PREVENTION; CANCER RESEARCH; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY PROGRAM; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HERBAL MEDICINE; HUMAN; INTERVENTION STUDY; PRIORITY JOURNAL; QUALITY CONTROL; CANCER CENTER; COMMUNITY CARE; COMPARATIVE STUDY; FEMALE; HEALTH CARE QUALITY; MALE; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

CANCER CARE FACILITIES; CLINICAL TRIALS; COMMUNITY HEALTH SERVICES; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; PROGRAM EVALUATION; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 27244444548     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.10.728     Document Type: Article

References (28)

1. Ni H, Simile C, Hardy AM: Utilization of complementary and alternative medicine by United States adults: Results from the 1999 National Health Interview Survey. Med Care 40:353-358, 2002
2. Wetzel M, Kaptchuk T, Haramati A, et al: Complementary and alternative medical therapies: Implications for medical education. Ann Intern Med 138:191-197, 2003
3. Eisenberg D, David R, Ettner S, et al: Trends in alternative medicine use in the United States, 1990-1997. JAMA 289:1569-1575, 1998
4. Barnes PM, Powell-Griner E, McFann K, et al: Complementary and alternative medicine use among adults: United States 2002. Adv Data 343:1-20, 2004
5. Sparber A, Wootton JC: Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies. J Altern Complement Med 7:281-287, 2001
6. Metz J, Jones H, Devine P, et al: Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer J 7:149-154, 2001
7. Jones H, Metz J, Devine P, et al: Rates of unconventional medical therapy use in patients with prostate cancer: Standard history versus directed questions. Urology 59:272-276, 2002
8. Kao D, Devine P: Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88:615-619, 2000
9. Miller M, Boyer M, Butow P, et al: The use of unproven methods of treatment by cancer patients: Frequency, expectations and cost. Support Care Cancer 6:337-347, 1998
10. Richardson M, Sanders T, Palmer J, et al: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505-2521, 2000
11. Ott MJ: Complementary and alternative therapies in cancer symptom management. Cancer Pract 10:162-166, 2002
12. Paltiel O, Avitzour M, Peretz T, et al: Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19:2439-2448, 2001
13. Burstein H, Gelber S, Guadagnoli E, et al: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340: 1733-1739, 1999
14. National Cancer Institute: Cancer research portfolio. Available at: http://researchportfolio .cancer.gov.
15. White JD: Complementary, alternative, and unproven methods of cancer treatment, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (6th ed). Philadelphia, PA, Lippincott, Williams & Wilkins, 2001, pp 3147-3157
16. National Cancer Institute, Office of Cancer Complementary and Alternative Medicine: Understanding CAM. Available at: http://cancer.gov/cam/ health_understanding.html
17. Office of Cancer Complementary and Alternative Medicine: Expert Panels in Cancer CAM Research: Developing the State of the Science in Research Methodologies. Bethesda, MD, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, DHHS publication 03-5427, 2003
18. Smith W: Research methodology: Implications for CAM pain research. Clin J Pain 20:3-7, 2004
19. Schaffner KF: Assessments of efficacy in biomedicine: The turn toward methodological pluralism, in Callahan D (ed): The Role of Complementary and Alternative Medicine: Accommodating Pluralism. Washington, DC, Georgetown University Press, 2002
20. Hufford D: CAM and cultural diversity: Ethics and epistemology converge, in Callahan D (ed): The Role of Complementary and Alternative Medicine: Accommodating Pluralism. Washington, DC, Georgetown University Press, 2002
21. O'Connor B: Personal experience, popular epistemology, and complementary and alternative medicine research, in Callahan D (ed): The Role of Complementary and Alternative Medicine: Accommodating Pluralism. Washington, DC, Georgetown University Press, 2002
22. Miles M, Huberman A: Qualitative Data Analysis: An Expanded Sourcebook (2nd ed). Thousand Oaks, CA, Sage Publications, 1994
23. White J: PC-SPES: A lesson for future dietary supplement research. J Natl Cancer Inst 94:1261-1262, 2002
24. Dasgupta A: Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol 120:127-137, 2003
25. Sparreboom A, Cox MC, Acharya MR, et al: Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 22:2489-2503, 2004
26. Mathijssen RH, Verweij J, de Bruijn P, et al: Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94:1247-1249, 2002
27. Persinger MA: Enhanced incidence of "the sensed presence" in people who have learned to meditate: Support for the right hemispheric intrusion hypothesis. Percept Mot Skills 75:1308-1310, 1992 (3 pt 2)
28. Kaptchuk TJ, Berman B, Mausell RB: The placebo and complementary and alternative medicine: Historical, scientific, and methodological considerations, in Office of Cancer Complementary and Alternative Medicine (ed): Expert Panels in Cancer CAM Research: Developing the State of the Science in Research Methodologies. Bethesda, MD, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, DHHS publication 03-5427, 2003